Circadian disruption in experimental cancer processes

Integrative Cancer Therapies

Volumn 8, Issue 4, 2009, Pages 298-302

  Filipski, Elisabeth ^a,b   Lévi, Francis ^a,b  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Cancer proliferation; Carcinogenesis; Circadian timing system; Clock genes; Jetlag; Meal timing; Mice; Suprachiasmatic nuclei

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE INHIBITOR; DIETHYLNITROSAMINE; MYC PROTEIN; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; PROTEIN P53; REV PROTEIN; ROSCOVITINE;

ANIMAL MODEL; BODY TEMPERATURE; CELL CYCLE; CIRCADIAN RHYTHM; CORTICOSTERONE RELEASE; EXPERIMENTAL NEOPLASM; FEEDING BEHAVIOR; GENE EXPRESSION; JET LAG; LIGHT DARK CYCLE; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; OSTEOSARCOMA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; SUPRACHIASMATIC NUCLEUS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CHRONIC DISEASE; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FOOD; JET LAG SYNDROME; MALE; MICE; NEOPLASMS, EXPERIMENTAL; PHOTOPERIOD; SUPRACHIASMATIC NUCLEUS;

EID: 77949411690     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735409352085     Document Type: Review

References (37)

1. Klein DCMR, Reppert SM. The Suprachiasmatic Nucleus. The Mind's Clock. New York, NY: Oxford University Press; 1991.
2. Innominato PF, Focan C, Gorlia T, et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 2009;69:4700-4707.
3. Mormont MC, Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer. 2003;97:155-169.
4. Mormont MC, Waterhouse J, Bleuzen P, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 2000;6:3038-3045.
5. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994-1000.
6. Pukkala E, Aspholm R, Auvinen A, et al. Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ. 2002;325:567.
7. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control. 001;12:95-101.
8. Reynolds P, Cone J, Layefsky M, Goldberg DE, Hurley S. Cancer incidence in California flight attendants (United States). Cancer Causes Control. 2002;13:317-324.
9. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001;93: 1563-1568.
10. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst. 2003;95:825-828.
11. Conlon M, Lightfoot N, Kreiger N. Rotating shift work and risk of prostate cancer. Epidemiology. 2007;18:182-183.
12. Hansen J. Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control. 2006;17:531-537.
13. Kubo T, Ozasa K, Mikami K, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol. 2006;164:549-555.
14. Lahti TA, Partonen T, Kyyronen P, Kauppinen T, Pukkala E. Night-time work predisposes to non-Hodgkin lymphoma. Int J Cancer. 2008;123:2148-2151.
15. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005;41:2023-2032.
16. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006;17: 108-111.
17. Viswanathan AN, Schernhammer ES. Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett. 2009;281:1-7.
18. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shiftwork, painting, and fire-fighting. Lancet Oncol. 2007;8: 1065-1066.
19. Wise J. Danish night shift workers with breast cancer awarded compensation. BMJ. 2009;338:b1152.
20. Maywood ES, Smith E, Hall SJ, Hastings MH. A thalamic contribution to arousal-induced, non-photic entrainment of the circadian clock of the Syrian hamster. Eur J Neurosci. 1997;9: 1739-1747.
21. Glasgow LA, Crane JL Jr, Kern ER. Antitumor activity of interferon against murine osteogenic sarcoma cells in vitro. J Natl Cancer Inst. 1978;60:659-666.
22. Corbett TH, Roberts BJ, Leopold WR, et al. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res. 1984;44: 717-726.
23. Filipski E, King VM, Li X, et al. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst. 2002;94: 690-697.
24. Filipski E, Delaunay F, King VM, et al. Effects of chronic jet lag on tumor progression in mice. Cancer Res. 2004;64: 7879-7885.
25. Depres-Brummer P, Levi F, Metzger G, Touitou Y. Lightinduced suppression of the rat circadian system. Am J Physiol. 1995;268(5, pt 2):R1111-R1116.
26. Filipski E, Innominato PF, Wu M, et al. Effects of light and food schedules on liver and tumor molecular clocks in mice. J Natl Cancer Inst. 2005;97:507-517.
27. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111:41-50.
28. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302:255-259.
29. Bouzahzah B, Pavier D, Barbason H. The role of corticoids, adrenalectomy, phenobarbital and pentobarbital in the promotion of DEN-hepatocarcinogenesis. In Vivo. 1998;12: 411-419.
30. Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 2000;14:2950-2961.
31. Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M. Entrainment of the circadian clock in the liver by feeding. Science. 2001;291:490-493.
32. Hara R, Wan K, Wakamatsu H, et al. Restricted feeding entrains liver clock without participation of the suprachiasmatic nucleus. Genes Cells. 2001;6:269-278.
33. Wu MW, Li XM, Xian LJ, Levi F. Effects of meal timing on tumor progression in mice. Life Sci. 2004;75:1181-1193.
34. Meijer L, Borgne A, Mulner O, et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem. 1997;243:527-536.
35. Knockaert M, Greengard P, Meijer L. Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci. 2002; 23: 417-425.
36. Bach S, Knockaert M, Reinhardt J, et al. Roscovitine targets, protein kinases and pyridoxal kinase. J Biol Chem. 2005;280: 31208-31219.
37. Iurisci I, Filipski E, Reinhardt J, et al. Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res. 2006;66: 10720-10728.